Genomics

A ballpoint pen rests on top of a stack of documents ready for signing

Boehringer continues kidney dealmaking with $120M Variant pact

Boehringer unveiled its second kidney-focused collab in recent weeks, this time penning a deal worth up to $120 million with genomics-focused Variant.

James Waldron Jan 6, 2026 10:45am

Leader of National Human Genome Research Institute put on leave

Apr 1, 2025 10:13am

UPDATE: Another NIH leader is out amid Trump admin shake-up

Mar 21, 2025 10:44am

Illumina maps out entry into spatial transcriptomics

Feb 20, 2025 11:00am

Saudi Arabia sets sights on becoming a biotech hub

Jan 25, 2024 10:38am

Ultima inks deal to bring '$100 genome' to cancer patients

Apr 10, 2023 10:33am